[24] Zhang, C., Vincelette, L
adult obesity rate, calculated as having a BMI of 30 or higher, has gradually declined to 37% in 2025, dropping from a record high of 39.9% in 2022, according to a survey by the Gallup National Health and Well-Being Index released on Oct
Empire's course devotes a full module to these regulatory and documentation requirements
Non-GLP-1 Medications For those who may not tolerate GLP-1 receptor agonists or are looking for different approaches, there are other FDA-approved weight loss medications to consider: Phentermine-Topiramate (Qsymia ): A combination medication that helps suppress appetite and increase energy expenditure
Case presentation We present the case of a 63-year-old Caucasian male with widespread hyperpigmentation of the hard palate associated with a 9-year history of imatinib therapy to treat CML